| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000014838 |
| Receipt No. | R000017111 |
| Official scientific title of the study | Study on the efficacy of 5ASA oral formula and suppository against relapse of proctitis |
| Date of disclosure of the study information | 2014/08/12 |
| Last modified on | 2018/08/15 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Study on the efficacy of 5ASA oral formula and suppository against relapse of proctitis | |
| Title of the study (Brief title) | Oral vs. suppository 5ASA against relapse of proctitis | |
| Region |
|
|
| Condition | ||
| Condition | proctitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the efficacy of remission induction in relapsed proctitis between 5ASA suppository and 5ASA oral formula |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | improvement in endoscopic Mayo score 4 weeks after the intervention |
| Key secondary outcomes | proportion of patients without relapse of rectal bleeding after 1 year of maintenance therapy |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | asacol 3.6g t.i.d 4 weeks | |
| Interventions/Control_2 | pentasa suppository 1g/day 4 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Having been diagnosed as proctitis by colonoscopy more than 6 months before
Having been on maintenance therapy with oral 5ASA (2.4g/day or less), oral sulfasalazine (3g/day or less), sulfasalazine suppository, or 5ASA suppository(1 in two days or less), or no maintenance therapy, which has not been changed for at least 2 months prior to the study entry Bleeding Mayo score > 0 Given written informed consent Eendoscopic Mayo score > 0 No active inflammation in area more than 15cm from the anal verge on colonoscopy |
|||
| Key exclusion criteria | Pregnant or nursing female
Patients who received steroids, immunosuppressants, immunomodulators, anti-TNF alpha, or leucocytapheresis within 3 months before the study entry Those with severe liver or renal dysfunction Those with a history of hypersensitivity against mesalazine Those who were regarded inadequate for this study |
|||
| Target sample size | 140 | |||
| Research contact person | |
| Name of lead principal investigator | Nobuyuki Matsuhashi |
| Organization | NTT Medical Center Tokyo |
| Division name | Dept of Gastroenterology |
| Address | 5-9-22 Higashigotanda Shinagawa-ku, Tokyo |
| TEL | 03-3448-6245 |
| nmatuha-tky@umin.ac.jp | |
| Public contact | |
| Name of contact person | Nobuyuki Matsuhashi |
| Organization | NTT Medical Center Tokyo |
| Division name | Dept of Gastroenterology |
| Address | 5-9-22 Higashigotanda Shinagawa-ku, Tokyo |
| TEL | 03-3448-6245 |
| Homepage URL | |
| nmatuha-tky@umin.ac.jp | |
| Sponsor | |
| Institute | NTT Medical Center Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017111 |